Belinda is a competition/anti-trust and regulatory lawyer based in Sydney.
Belinda advises Australian and international corporate clients, utilities, and regulators on all aspects of competition law and the regulation of essential services, including energy, rail, ports and other infrastructure.
Belinda has extensive experience in advising on and obtaining clearance for domestic and cross-border mergers and acquisitions, with a particular focus on multi-jurisdictional matters. Her merger clearance experience is well recognised in the Australian legal market. Belinda also advises on the structuring of joint ventures and other collaborative arrangements within the bounds of competition law, anti-competitive conduct and matters of compliance. She has a depth of experience in advising on the economic regulation of utilities, including the electricity, gas, and transport sectors under various Australian regulation, in addition to the access regime under State-based and national competition laws.
Belinda is a dedicated competition/anti-trust lawyer with over 10 years’ experience. Prior to joining private practice in 2008, Belinda was a lawyer with the Australian Competition and Consumer Commission (ACCC) advising on mergers and acquisitions, exclusive dealing authorisations, and other competition law litigation. She also worked as an investigator in the enforcement division and as a project officer in the telecommunications group of the ACCC, and in the gas division of the Australian Energy Regulator.
The prohibition on acquiring shares or assets where the effect is likely to be a substantial lessening of competition in a market applies to all transactions, whether large or small by value or volume, the industry or the size of the business. .
November 14, 2018
There are over 140 jurisdictions globally that have some form of merger control. For multinational companies this means that transactions are likely to trigger filings in several different jurisdictions..
November 06, 2017
A cross-border team from global law firm Norton Rose Fulbright is advising US-based medtech giant Varian Medical Systems, Inc. on its proposed AU$1.58bn acquisition of all of the issued share capital of ASX-listed life sciences company Sirtex Medical Limited, currently the largest takeover deal announced in Australia for 2018..
February 08, 2018
Global law firm Norton Rose Fulbright to add another three partners in Australia.
November 20, 2017